Tata Capital Files ₹15,000 Crore IPO via Confidential DRHP | Check All Details Here
Posted by : sachet | Thu Apr 10 2025

Tata Capital Limited, one of the leading NBFC of Tata Group, has filed a confidential DRHP (Draft Red Hearing Prospectus) with SEBI. Tata Capital is to announce a ₹15,000 crore IPO soon. This move would be one of the biggest upcoming IPOs in India’s financial service space. Here are the details about Tata Capital IPO and what investors can expect from this IPO.
Tata Capital IPO: Key Highlights
As per the regulatory filings, Tata Capital’s IPO will bring:
- Fresh Issue: Up to 2.3 crore equity shares will be issued under fresh issue with a face value of ₹10 per share.
- Offer For Sale: Existing shareholders of Tata Capital will offer shares for sale.
- IPO Size: ₹15,000 crore
- Listing On: BSE and NSE
- Filing Status: Confidential DRHP Filed with SEBI.
Proceeding with a confidential DRHP would offer Tata Capital flexibility to set the IPO structure and price band.
About Tata Capital Limited
Tata Capital was founded in 2007 and has become one of the most diversified NBFCs (Non-Banking Financial Corporations). It has a diversified portfolio of services, including consumer loans, SME loans, Business loans, wealth management, commercial finance, investment advisory, insurance, and card distribution. With 900+ branches in India, Tata Capital has built a strong omnichannel model serving retail, SME, and corporate customers.
Tata Capital IPO Book Running Lead Managers
Kotak Mahindra Capital, JP Morgan, Axis Capital, ICIC Securities, HSBC Securities, Citi, IIFL Capital, BNP Paribas, HDFC Bank, and SBI Capital Markets would be the book-running lead managers of the Tata Capital IPO.
Tata Capital IPO: Should Apply or Avoid?
Check the pros and cons to determine whether you should apply for the Tata Capital IPO filed with SEBI confidentially.
Pros of Tata Capital IPO
- Owned by Trusted Legacy Brand: Tata Group
- Robust Multi-Channel Distribution
- Consistent Financial Growth & Profit
- Deep Penetration in SME Lending Markets
- Solid Corporate Governance
- Risk Management Practices
Cons of Tata Capital IPO
- Exposure to Credit Cycles & Macro Risks
- Increasing Competition from Digital-First Fintechs
Wide footprints and profitable operation of Tata Capital, makes it one of the most stable and promising financial services IPO in 2025.
Tata Capital IPO Date
There is no official announcement for the Tata Capital IPO Date from stock exchanges. But, here could be the IPO timeline per the industry norms.
Particulars | Expected Time |
SEBI Review & Approval | Within 1 to 2 Months After Filing |
Price Band Declaration | 1 Month Before IPO |
Lot Size Declaration | 1 Month Before IPO |
Public Roadshows | 2 to 3 Weeks Before IPO |
Investor Meet | 2 to 3 Weeks Before IPO |
Final IPO Launch | Mid to Late 2025 (Expected) |
Summary
The Tata Capital ₹15,000 crore IPO is among the biggest IPO in 2025. This issue, being a part of the Tata heritage and with decent financials, stands to benefit from huge interest from retail, HNI, and institutional investors.
Investors should watch for:
- SEBI Approvals
- Price band and Grey Market Premium (GMP)
- Subscription details
- Allotment date, listing gains
For live stocks updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Explore Other News Articles
Suzlon Share Price Falls 3.05% Amid Order Cancellations and Selloffs
Zomato Rebrands to Eternal Limited: Stock Opened Higher at ₹216 Amid COO Exit
Stock Market Today: Sensex Down 400 Pnts Amid RBI’s Repo Rate Cut; Check Future Outlook
RBI Monetary Policy Meeting 2025 | 25 bps Repo Rate Cut by Sanjay Malhotra Amid Easing Inflation
Stocks to Watch Today: 9th April 2025: NTPC, BPCL, HAL, NBCC, & More!

Related Posts
Weekly Update-11 April 2025
Tata Motors Share Rallies 5% Amid Positive Global Market Sentiments: Check Key Highlights
Biocon Share Price in Focus Today: Biocon Gets FDA Approval for Bevacizumab Biosimilar
Stock Market Today: Sensex Jumps 1,100 Pts: Nifty Scales 22,800 as Gains Extend; Check Details
Stocks to Watch Today: 11th April 2025 | Sun Pharma, RITES, BHEL, TATA MOTORS, NBCC, SRF & More!
TCS Q4 Results Miss Estimates: Net Profit Down 2% YoY | ₹30 Dividend Declared